Clinical Trial

Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.

Study acronym: SIERRA
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 22, 2024 (before its estimated March 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of DEP114 in the treatment of Moderate to Severe Persistent Allergic Rhinitis in children aged between 6 and 11 years.
Trial Details
NCT Number NCT06272409
Lead Sponsor EMS
Conditions Allergic Rhinitis
Enrollment 318 participants
Start Date 2025-02-15
Primary Completion 2025-03-15 (estimated)
Study Completion 2027-04-15 (estimated)
Updated on ClinicalTrials.gov 2024-02-22